Molecular diagnostics for cancer/skin disease
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Steve Cohen / Point72 | 80 | New buy | 357,317 | $8,522,010 | 0.0% |
| Paul Tudor Jones / Tudor | 63 | Trimmed -94% | 14,462 | $344,919 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-08-17.